Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-02

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for acetazolamide filed by Lifestar Pharma LLC under the ANDA program. The document does not specify a new indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)